Rising Prevalence of Infectious Diseases is Fueling Europe Biosafety Cabinet Market
Infectious diseases are rapidly increasing across the region. The World Health Organization reported that infectious diseases are likely to cause millions of deaths each year. Additionally, the ease of international travel has led to an additional layer of complexity in terms of tackling with the infectious diseases which led to the pandemic conditions. Moreover, changing climatic conditions on a global level have contributed to the prevalence of infectious diseases as it can increase the severity of the infectious diseases. As per United Nations Office for Disaster Risk Reduction (UNDDR), climate change can intensify the infectious diseases encountered by humans by 58%. Since the 1970s, about 40 infectious diseases have been discovered, including SARS, MERS, Ebola virus disease, chikungunya, avian flu, swine flu, zika virus infection, and most recently, COVID-19. Antibiotic techniques such as vaccinations against influenza help reduce the illness by 17% and medical visits and hospitalizations by 18% and 19%, respectively. Patient samples are collected to conduct a vast number of experiments and studies for formulating anti-dotes and vaccines to curb infectious diseases. Additionally, appropriate care and management of these samples require a suitable workstation and sanitized environment. These controlled and disinfected environments are mostly possible with the use of biological safety cabinets, which propels the growth of the Europe biosafety cabinet market.Europe Biosafety Cabinet Market Overview
The Europe biosafety cabinet market is segmented into Germany, the UK, France, Italy, Spain, and the rest of Europe. Germany dominated the market in 2023. Germany has the second-largest medical biotechnology sector after the US. Presence of well-established and start-up companies in Germany and support from government and research entities encourage the growth of the sector across the country. Germany has a hi-tech research infrastructure and internationally renowned scientists. The country has positioned itself as a well-established international medical biotechnology hub. Therefore, the surging medical biotechnology sectors have increased the use of laboratory consumables including biosafety cabinets which is expected to drive the market growth in in the coming years. As per the Germany Trade & Invest article published for the biotechnology sector in 2021, Germany has nearly 744 dedicated biotechnology companies. These companies invested nearly US$ 4.1 billion (€3.8 billion) in 2021 for research and development. They also have generated revenue of ∼US$ 28.8 billion (€ 26.3 billion).Exhibit: Europe Biosafety Cabinet Market Revenue and Forecast to 2028 (US$ Million)
Europe Biosafety Cabinet Market Segmentation
The Europe biosafety cabinet market is segmented into products handled, category, type, application, end user, and country.Based on products handled, the Europe biosafety cabinet market is bifurcated into biological products and toxic products. The biological products segment held a larger share of the Europe biosafety cabinet market in 2023.
Based on category, the Europe biosafety cabinet market is segmented into work trays, side panel construction, and accessories. The work trays segment held the largest share of the Europe biosafety cabinet market in 2023.
Based on type, the Europe biosafety cabinet market is segmented into class I biosafety cabinet, class II type A2 & class II type B1, class II type B2 biosafety cabinet, class II biosafety cabinet, customized cabinets, and others. The class II type A2 & class II type B1 segment held the largest share of the Europe biosafety cabinet market in 2023.
Based on application, the Europe biosafety cabinet market is segmented into medical health, disease prevention, food safety, biological pharmacy, environment monitoring, and others. The disease prevention segment held the largest share of the Europe biosafety cabinet market in 2023.
Based on end user, the Europe biosafety cabinet market is segmented into academic centers, biotech & pharmaceutical companies, microbiology centers, research & development centers, hospitals & clinics, diagnostic laboratories, and others. The biotech & pharmaceutical companies segment held the largest share of the Europe biosafety cabinet market in 2023.
Based on country, the Europe biosafety cabinet market has been categorized into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Our regional analysis states that Germany dominated the Europe biosafety cabinet market in 2023.
ACMAS Technologies, Biobase Biodusty Co Ltd, Esco Group of Companies, Haier Biomedical, Kewaunee Scientific Corp, Labconco Corp, NuAire Inc, and Thermo Fisher Scientific Inc are the leading companies operating in the Europe biosafety cabinet market.
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- ACMAS Technologies
- Biobase Biodusty Co Ltd
- Esco Group of Companies
- Haier Biomedical
- Kewaunee Scientific Corp
- Labconco Corp
- NuAire Inc
- Thermo Fisher Scientific Inc
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 145 |
Published | July 2023 |
Forecast Period | 2023 - 2028 |
Estimated Market Value ( USD | $ 93.35 million |
Forecasted Market Value ( USD | $ 133.61 million |
Compound Annual Growth Rate | 7.4% |
Regions Covered | Europe |